Records containing: Invasive Breast Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-12-06A Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer
-
CLINICAL_TRIALS study record update · 2022-10-05A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
-
CLINICAL_TRIALS study record update · 2022-09-26A Phase Ib Trial Evaluating the Safety of Copanlisib, Letrozole, and Palbociclib in Metastatic Breast Cancer and Phase II Trial Comparing the Molecular Effects of Neoadjuvant Copanlisib in Combination With Palbociclib and Letrozole, vs. Copanlisib With Letrozole, vs. Palbociclib With Letrozole for Patients With Hormone Receptor Positive, HER2 Normal Breast Cancer
-
CLINICAL_TRIALS study record update · 2022-08-16TRI-fraction Radiotherapy Utilized to Minimize Patient Hospital Trips : A Phase II Trial (TRIUMPH-T Trial)
-
CLINICAL_TRIALS study record update · 2022-06-08Defining the Molecular Profile of Breast Cancer in Uganda and Its Clinical Implications
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-02-10A Pilot Study of Talazoparib as a Neoadjuvant Study in Patients With a Diagnosis of Invasive Breast Cancer and a Deleterious BRCA Mutation
-
CLINICAL_TRIALS study record update · 2021-12-28A Multicenter Phase II Study of Docosahexaenoic Acid (DHA) in Patients With a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease
-
CLINICAL_TRIALS study record update · 2021-11-19Randomized Trial of Hypofractionated Whole Breast Irradiation Versus Conventionally Fractionated Whole Breast Irradiation for Ductal Carcinoma In Situ and Early Invasive Breast Cancer
-
CLINICAL_TRIALS study record update · 2021-10-28A Phase 1/2 Study of Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
-
CLINICAL_TRIALS study record update · 2021-10-26Enhancing A Home-Based Walking Intervention Among Breast Cancer Survivors With rTMS: Feasibility and Limited Efficacy Testing
-
CLINICAL_TRIALS study record update · 2021-04-13Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
-
CLINICAL_TRIALS study record update · 2019-10-31A Pilot Study of Broccoli Sprout Extract in Patients With Breast Cancer
-
CLINICAL_TRIALS study record update · 2019-09-20A Single Arm, Phase II Study of Single Agent Trametinib Followed by Trametinib in Combination With GSK2141795 in Patients With Advanced Triple Negative Breast Cancer
-
CLINICAL_TRIALS study record update · 2019-06-18Changes in Intestinal Microbiota in Association With Chemotherapy Treatment
-
CLINICAL_TRIALS study record update · 2019-05-20Phase I and Phase I Trastuzumab Cohort Study of Entinostat, Lapatinib and Trastuzumab in Patients With HER2-Positive Metastatic Breast Cancer in Whom Trastuzumab Has Failed
-
CLINICAL_TRIALS study record update · 2018-12-27An Investigator Initiated Registry of Simple Oral Therapy for Low Risk Breast Cancer (SOLR)
-
CLINICAL_TRIALS study record update · 2018-07-23A Phase 1 Trial of MK-2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole Plus Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2016-08-23Endocrine Therapy With or Without Anti-VEGF Therapy: A Randomized, Phase III Trial of Endocrine Therapy Alone or Endocrine Therapy Plus Bevacizumab (NSC 704865) for Women With Hormone Receptor-Positive Advanced Breast Cancer
-
CLINICAL_TRIALS study record update · 2015-11-11A Phase II Study of Preoperative Capecitabine in Women With Operable Breast Cancer
-
CLINICAL_TRIALS study record update · 2013-04-10Phase II Study of Purging of Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer Patients